Encompass Health Corp (EHC) shareholders
Close on Nov 17, 2026Market cap $13.60BP/E 22.5Yield 0.52%
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 9,125,779 | 9.10% | 13G (passive) amendment | Dec 31, 2023 |
| Vanguard Capital Management | 5,233,622 | 5.26% | 13G (passive) | Mar 31, 2026 |
| T. Rowe Price Associates, Inc. | 5,056,225 | 5.10% | 13G (passive) | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of EHC | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 10,484,385 | 10.63% | $1.06B | −284,328 | 0.02% |
| Price T Rowe Associates Inc /Md/ | 5,055,801 | 5.12% | $511.04M | +455,252 | 0.05% |
| Vanguard Portfolio Management LLC | 4,924,664 | 4.99% | $497.79M | −34,881 | 0.02% |
| Vanguard Capital Management LLC | 4,475,896 | 4.54% | $452.42M | +9,659 | 0.01% |
| Wellington Management Group Llp | 3,278,739 | 3.32% | $331.41M | −570,116 | 0.06% |
| State Street Corp | 3,185,798 | 3.23% | $322.02M | +40,824 | 0.01% |
| Citadel Advisors LLC | 2,563,104 | 2.60% | $259.08M | +2,051,217 | 0.03% |
| Alliancebernstein L.P. | 2,471,751 | 2.51% | $239.09M | −149,494 | 0.08% |
| Fuller & Thaler Asset Management, Inc. | 2,460,657 | 2.49% | $248.72M | +230,678 | 0.68% |
| Two Sigma Investments, LP | 2,267,668 | 2.30% | $229.22M | +45,567 | 0.17% |
| Geode Capital Management, LLC | 1,890,743 | 1.92% | $191.16M | −7,924 | 0.01% |
| Dimensional Fund Advisors LP | 1,743,028 | 1.77% | $176.19M | +68,244 | 0.03% |
| Goldman Sachs Group Inc | 1,550,797 | 1.57% | $156.75M | −254,924 | 0.01% |
| Invesco Ltd. | 1,161,108 | 1.18% | $117.36M | −2,224,997 | 0.01% |
| Arrowstreet Capital, Limited Partnership | 1,156,930 | 1.17% | $116.94M | −25,644 | 0.05% |
| Norges Bank | 1,154,864 | 1.17% | $116.73M | New | 0.01% |
| William Blair Investment Management, LLC | 1,151,085 | 1.17% | $116.35M | +347,934 | 0.35% |
| Morgan Stanley | 1,146,873 | 1.16% | $115.93M | +249,891 | 0.01% |
| JPMorgan Chase & Co | 1,133,561 | 1.15% | $114.84M | −97,910 | 0.01% |
| Raymond James Financial Inc | 1,064,233 | 1.08% | $107.57M | −2,773 | 0.03% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 597 | 96M | 97.0% | 66 / 225 | 223 / 41 | 11M | 12M |
| Q1 2026 | 580 | 96M | 97.7% | 77 / 231 | 197 / 83 | 21M | 17M |
| Q4 2025 | 594 | 102M | 100.0% | 83 / 176 | 257 / 78 | 17M | 10M |
| Q3 2025 | 604 | 95M | 96.4% | 55 / 239 | 230 / 50 | 10M | 10M |
| Q2 2025 | 607 | 95M | 96.3% | 113 / 206 | 219 / 37 | 8M | 10M |
| Q1 2025 | 537 | 97M | 98.0% | 60 / 202 | 194 / 60 | 7M | 6M |
| Q4 2024 | 544 | 96M | 97.1% | 98 / 208 | 163 / 31 | 11M | 12M |
| Q3 2024 | 483 | 98M | 99.0% | 50 / 171 | 198 / 39 | 18M | 9M |
| Q2 2024 | 478 | 98M | 99.3% | 74 / 173 | 166 / 29 | 7M | 9M |
| Q1 2024 | 436 | 100M | 100.0% | 60 / 155 | 150 / 57 | 8M | 9M |
| Q4 2023 | 435 | 101M | 100.0% | 63 / 147 | 155 / 35 | 13M | 6M |
| Q3 2023 | 413 | 94M | 95.1% | 57 / 132 | 157 / 29 | 5M | 5M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
560 funds held EHC in Q2 2026, 43% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of EHC | Value | % of fund | As of |
|---|---|---|---|---|---|
| iShares Core S&P Mid-Cap ETF | 3,394,861 | 3.44% | $343.15M | 0.28% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 3,150,844 | 3.19% | $318.49M | 0.01% | Jun 30, 2026 |
| Fullerthaler Behavioral Small Cap Equity | 2,347,546 | 2.38% | $237.29M | 1.87% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 2,275,892 | 2.31% | $230.05M | 0.12% | Jun 30, 2026 |
| Vanguard Small-Cap Value Index Fund | 1,441,139 | 1.46% | $145.67M | 0.21% | Jun 30, 2026 |
| Vanguard Health Care Fund | 1,252,498 | 1.27% | $139.11M | 0.36% | Jul 31, 2026 |
| T. Rowe Price U.S. Large-Cap Core Fund, Inc. | 1,160,103 | 1.18% | $117.26M | 0.65% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 1,137,424 | 1.15% | $114.97M | 0.12% | Jun 30, 2026 |
| Vanguard Explorer Fund | 1,034,944 | 1.05% | $114.95M | 0.52% | Jul 31, 2026 |
| SMALLCAP World Fund Inc | 848,027 | 0.86% | $85.72M | 0.09% | Jun 30, 2026 |
| iShares S&P Mid-Cap 400 Growth ETF | 593,485 | 0.60% | $59.99M | 0.53% | Jun 30, 2026 |
| Small Cap Growth Fund | 522,726 | 0.53% | $58.06M | 1.04% | Jul 31, 2026 |
| Fidelity Extended Market Index Fund | 518,122 | 0.53% | $54.84M | 0.13% | May 31, 2026 |
| State Street(R) SPDR(R) Portfolio S&P 400(TM) Mid Cap ETF | 502,111 | 0.51% | $50.75M | 0.28% | Jun 30, 2026 |
| T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund | 483,146 | 0.49% | $48.84M | 0.50% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Mark J. Tarr | President & CEO, Director | 267,814 | 0.27% | Aug 11, 2026 |
| John Patrick Darby | EVP, Gen Counsel & Secretary | 79,899 | 0.08% | Sep 1, 2026 |
| Andrew L. Price | Chief Accounting Officer | 69,483 | 0.07% | Sep 1, 2026 |
| Douglas E. Coltharp | EVP & Chief Financial Officer | 241,368 | 0.24% | Aug 11, 2026 |
| Patrick William Tuer | EVP, Chief Operating Officer | 24,755 | 0.03% | May 12, 2026 |
| Edmund Fay | Sr. Vice Pres. and Treasurer | 89,325 | 0.09% | Mar 10, 2026 |
| Elissa Joy Charbonneau | Chief Medical Officer | 17,644 | 0.02% | Mar 3, 2026 |
| Edward M. Christie III | Director | 9,577 | 0.01% | Oct 19, 2026 |
| Joan E. Herman | Director | 49,724 | 0.05% | Oct 19, 2026 |
| Greg D. Carmichael | Director | 20,377 | 0.02% | Oct 19, 2026 |
| Leslye G. Katz | Director | 49,724 | 0.05% | Oct 19, 2026 |
| Nancy M. Schlichting | Director | 23,010 | 0.02% | Oct 19, 2026 |
| Cain A. Hayes | Director | 2,100 | 0.00% | Oct 19, 2026 |
| Kevin J. O'Connor | Director | 11,600 | 0.01% | Oct 19, 2026 |
| Christopher R. Reidy | Director | 18,081 | 0.02% | Oct 19, 2026 |
| Terrance Williams | Director | 16,887 | 0.02% | Oct 19, 2026 |
| Patricia Anne Maryland | Director | 14,764 | 0.01% | Jul 16, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Edward M. Christie III Director | Oct 19, 2026 | Award | +221 | $126.63 | $27.99K | 9,577 |
| Christopher R. Reidy Director | Oct 19, 2026 | Award | +284 | $126.89 | $36.04K | 18,081 |
| Greg D. Carmichael Director | Oct 15, 2026 | Award | +28 | – | – | 20,377 |
| Terrance Williams Director | Oct 15, 2026 | Award | +28 | – | – | 16,887 |
| Nancy M. Schlichting Director | Oct 15, 2026 | Award | +38 | – | – | 23,010 |
| Joan E. Herman Director | Oct 15, 2026 | Award | +81 | – | – | 49,724 |
| Edward M. Christie III Director | Oct 15, 2026 | Award | +11 | – | – | 9,356 |
| Christopher R. Reidy Director | Oct 15, 2026 | Award | +20 | – | – | 17,797 |
| Cain A. Hayes Director | Oct 15, 2026 | Award | +4 | – | – | 2,100 |
| Kevin J. O'Connor Director | Oct 15, 2026 | Award | +18 | – | – | 11,600 |
| Leslye G. Katz Director | Oct 15, 2026 | Award | +81 | – | – | 49,724 |
| Andrew L. Price Chief Accounting Officer | Aug 31, 2026 | Sale | −5,211 | $120.93 | $630.17K | 69,483 |
| John Patrick Darby EVP, Gen Counsel & Secretary | Aug 31, 2026 | Option exercise | +4,858 | $35.06 | $170.32K | 79,899 |
| John Patrick Darby EVP, Gen Counsel & Secretary | Aug 31, 2026 | Sale | −4,858 | $121.09 | $588.26K | 75,041 |
| John Patrick Darby EVP, Gen Counsel & Secretary | Aug 10, 2026 | Sale | −8,906 | $125.95 | $1.12M | 75,041 |
| Mark J. Tarr President & CEO, Director | Aug 10, 2026 | Sale | −1,579 | $126.06 | $199.05K | 267,814 |
| Mark J. Tarr President & CEO, Director | Aug 10, 2026 | Sale | −171,569 | $125.46 | $21.53M | 269,393 |
| Douglas E. Coltharp EVP & Chief Financial Officer | Aug 10, 2026 | Sale | −18,869 | $125.38 | $2.37M | 50,508 |
| Edward M. Christie III Director | Jul 16, 2026 | Award | +248 | $112.43 | $27.88K | 9,345 |
| Christopher R. Reidy Director | Jul 16, 2026 | Award | +319 | $112.40 | $35.86K | 17,777 |
| Greg D. Carmichael Director | Jul 15, 2026 | Award | +29 | – | – | 20,349 |
| Edward M. Christie III Director | Jul 15, 2026 | Award | +11 | – | – | 9,097 |
| Terrance Williams Director | Jul 15, 2026 | Award | +29 | – | – | 16,859 |
| Christopher R. Reidy Director | Jul 15, 2026 | Award | +21 | – | – | 17,458 |
| Kevin J. O'Connor Director | Jul 15, 2026 | Award | +19 | – | – | 11,582 |
| Joan E. Herman Director | Jul 15, 2026 | Award | +85 | – | – | 49,643 |
| Cain A. Hayes Director | Jul 15, 2026 | Award | +4 | – | – | 2,096 |
| Nancy M. Schlichting Director | Jul 15, 2026 | Award | +40 | – | – | 22,972 |
| Leslye G. Katz Director | Jul 15, 2026 | Award | +85 | – | – | 49,643 |
| Douglas E. Coltharp EVP & Chief Financial Officer | May 15, 2026 | Option exercise | +27,694 | $32.94 | $912.24K | 97,071 |
| Douglas E. Coltharp EVP & Chief Financial Officer | May 15, 2026 | Sale | −27,693 | $106.83 | $2.96M | 69,378 |
| Douglas E. Coltharp EVP & Chief Financial Officer | May 15, 2026 | Sale | −1 | $107.28 | $107 | 69,377 |
| Patrick William Tuer EVP, Chief Operating Officer | May 11, 2026 | Sale | −682 | $104.56 | $71.31K | 24,755 |
| Nancy M. Schlichting Director | May 7, 2026 | Award | +1,634 | – | – | 22,932 |
| Terrance Williams Director | May 7, 2026 | Award | +1,634 | – | – | 16,830 |
| Greg D. Carmichael Director | May 7, 2026 | Award | +1,634 | – | – | 20,320 |
| Edward M. Christie III Director | May 7, 2026 | Award | +1,634 | – | – | 9,086 |
| Leslye G. Katz Director | May 7, 2026 | Award | +1,634 | – | – | 49,558 |
| Christopher R. Reidy Director | May 7, 2026 | Award | +1,634 | – | – | 17,437 |
| Kevin J. O'Connor Director | May 7, 2026 | Award | +1,634 | – | – | 11,563 |
| Cain A. Hayes Director | May 7, 2026 | Award | +1,634 | – | – | 2,092 |
| Joan E. Herman Director | May 7, 2026 | Award | +1,634 | – | – | 49,558 |
| Edward M. Christie III Director | Apr 16, 2026 | Award | +261 | $106.17 | $27.71K | 7,452 |
| Christopher R. Reidy Director | Apr 16, 2026 | Award | +334 | $106.48 | $35.56K | 15,803 |
| Nancy M. Schlichting Director | Apr 15, 2026 | Award | +39 | – | – | 21,298 |
| Joan E. Herman Director | Apr 15, 2026 | Award | +85 | – | – | 47,924 |
| Leslye G. Katz Director | Apr 15, 2026 | Award | +85 | – | – | 47,924 |
| Edward M. Christie III Director | Apr 15, 2026 | Award | +9 | – | – | 7,191 |
| Christopher R. Reidy Director | Apr 15, 2026 | Award | +19 | – | – | 15,469 |
| Terrance Williams Director | Apr 15, 2026 | Award | +27 | – | – | 15,196 |
| Kevin J. O'Connor Director | Apr 15, 2026 | Award | +17 | – | – | 9,929 |
| Greg D. Carmichael Director | Apr 15, 2026 | Award | +27 | – | – | 18,686 |
| Cain A. Hayes Director | Apr 15, 2026 | Award | +1 | – | – | 458 |
| Edmund Fay Sr. Vice Pres. and Treasurer | Mar 9, 2026 | Sale | −11,937 | $107.00 | $1.28M | 89,325 |
| Edmund Fay Sr. Vice Pres. and Treasurer | Mar 9, 2026 | Gift | −3,000 | – | – | 86,325 |
| Elissa Joy Charbonneau Chief Medical Officer | Feb 28, 2026 | Tax withholding | −369 | $107.88 | $39.81K | 17,644 |
| Patrick William Tuer EVP, Chief Operating Officer | Feb 28, 2026 | Tax withholding | −545 | $107.88 | $58.79K | 25,437 |
| Douglas E. Coltharp EVP & Chief Financial Officer | Feb 28, 2026 | Tax withholding | −776 | $107.88 | $83.71K | 69,377 |
| John Patrick Darby EVP, Gen Counsel & Secretary | Feb 28, 2026 | Tax withholding | −416 | $107.88 | $44.88K | 83,947 |
| Andrew L. Price Chief Accounting Officer | Feb 28, 2026 | Tax withholding | −307 | $107.88 | $33.12K | 74,694 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Encompass Health's stock actually held short. Settlement fails (shares not delivered on time) peaked at 44,643 shares on Oct 7, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| John Patrick Darby Officer | Aug 31, 2026 | 4,858 | $588.26K | Aug 31, 2026 | Stock Option Exercise |
| Douglas E. Coltharp Officer | Aug 10, 2026 | 18,869 | $2.37M | Aug 10, 2026 | RSA Vesting |
| John Patrick Darby Officer | Aug 10, 2026 | 8,906 | $1.12M | Aug 10, 2026 | RSU Vesting |
| Mark J. Tarr Officer | Aug 10, 2026 | 173,148 | $21.72M | Aug 10, 2026 | Equity Plan |
| Douglas E. Coltharp Officer | May 15, 2026 | 27,694 | $2.96M | May 15, 2026 | Stock Option Exercise |
| Patrick William Tuer Officer | May 11, 2026 | 682 | $71.31K | May 11, 2026 | RSA Vesting |
| Mark J. Tarr Officer | Feb 11, 2026 | 150,000 | $16.74M | Feb 11, 2026 | RSA Vesting |
| Patrick William Tuer Officer | Feb 10, 2026 | 2,804 | $301.76K | Feb 10, 2026 | RSU Vesting |
| Patrick William Tuer Officer | Aug 27, 2025 | 1,020 | $126.06K | Aug 27, 2025 | RSU Vesting |
| Mark J. Tarr Officer | May 20, 2025 | 118,384 | $14.38M | May 20, 2025 | Stock Option Exercise |
| Douglas E. Coltharp Officer | Apr 29, 2025 | 43,575 | $5.02M | Apr 29, 2025 | Stock Option Exercise |
| John Patrick Darby Officer | Apr 29, 2025 | 14,858 | $1.71M | Apr 29, 2025 | Stock Option Exercise |
| Douglas E. Coltharp Officer | Aug 13, 2024 | 12,260 | $1.06M | Aug 13, 2024 | Stock Option Exercise |
| John Chidsey Officer | May 22, 2024 | 29,500 | $2.52M | May 22, 2024 | Vesting of restricted stock unit award |
| John Patrick Darby Officer | May 6, 2024 | 14,543 | $1.22M | May 6, 2024 | stock option exercise |
Congress trades
4 trades in Encompass Health reported by 1 member of the House
| Member | Type | Traded | Amount | Filed |
|---|---|---|---|---|
| Lisa McClain MI09 · spouse | Sold | Oct 31, 2025 | $1K–15K | Nov 21, 2025 |
| Lisa McClain MI09 · spouse | Sold | Oct 30, 2025 | $1K–15K | Nov 21, 2025 |
| Lisa McClain MI09 · spouse | Bought | Oct 30, 2025 | $1K–15K | Nov 21, 2025 |
| Lisa McClain MI09 · spouse | Bought | Jul 22, 2025 | $1K–15K | Aug 13, 2025 |
See a number that looks wrong?